The global market for Solid Phase Synthesis Carrier for Peptide Drug was valued at US$ 123 million in the year 2024 and is projected to reach a revised size of US$ 232 million by 2031, growing at a CAGR of 9.6% during the forecast period.
Compared to liquid-phase synthesis, solid-phase synthesis offers significant advantages, especially in peptide drug production. The solid-phase synthesis carrier immobilizes the starting amino acid, eliminating the need for complex separation and purification steps, thereby greatly enhancing synthesis efficiency. Its ease of operation and repetitive coupling and deprotection steps make it well-suited for automated production, improving manufacturing efficiency and consistency. Furthermore, this method increases the yield and purity of the target product, meeting the growing demands of downstream customers and accelerating the research and industrialization of peptide drugs.
North American market for Solid Phase Synthesis Carrier for Peptide Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Solid Phase Synthesis Carrier for Peptide Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Solid Phase Synthesis Carrier for Peptide Drug include Sunresin, Tianjin Nankai Hecheng Science & Technology, Zhejiang Zhengguang, Jiangsu Haipu Functional Materials, RawPEG, Merck, CEM Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Solid Phase Synthesis Carrier for Peptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Phase Synthesis Carrier for Peptide Drug.
The Solid Phase Synthesis Carrier for Peptide Drug market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid Phase Synthesis Carrier for Peptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Phase Synthesis Carrier for Peptide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sunresin
Tianjin Nankai Hecheng Science & Technology
Zhejiang Zhengguang
Jiangsu Haipu Functional Materials
RawPEG
Merck
CEM Corporation
by Type
Hydroxyl Resins
Chloromethyl Resins
Amino Resins
Others
by Application
Tumors
Metabolic Diseases
Cardiovascular
Orthopedics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Solid Phase Synthesis Carrier for Peptide Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Solid Phase Synthesis Carrier for Peptide Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Solid Phase Synthesis Carrier for Peptide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Solid Phase Synthesis Carrier for Peptide Drug Market Overview
1.1 Product Definition
1.2 Solid Phase Synthesis Carrier for Peptide Drug by Type
1.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Hydroxyl Resins
1.2.3 Chloromethyl Resins
1.2.4 Amino Resins
1.2.5 Others
1.3 Solid Phase Synthesis Carrier for Peptide Drug by Application
1.3.1 Global Solid Phase Synthesis Carrier for Peptide Drug Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tumors
1.3.3 Metabolic Diseases
1.3.4 Cardiovascular
1.3.5 Orthopedics
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Estimates and Forecasts (2020-2031)
1.4.4 Global Solid Phase Synthesis Carrier for Peptide Drug Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Manufacturers (2020-2025)
2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Solid Phase Synthesis Carrier for Peptide Drug, Industry Ranking, 2023 VS 2024
2.4 Global Solid Phase Synthesis Carrier for Peptide Drug Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Solid Phase Synthesis Carrier for Peptide Drug Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Product Offered and Application
2.8 Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Date of Enter into This Industry
2.9 Solid Phase Synthesis Carrier for Peptide Drug Market Competitive Situation and Trends
2.9.1 Solid Phase Synthesis Carrier for Peptide Drug Market Concentration Rate
2.9.2 Global 5 and 10 Largest Solid Phase Synthesis Carrier for Peptide Drug Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Solid Phase Synthesis Carrier for Peptide Drug Production by Region
3.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Region (2020-2031)
3.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Solid Phase Synthesis Carrier for Peptide Drug by Region (2026-2031)
3.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Solid Phase Synthesis Carrier for Peptide Drug Production Volume by Region (2020-2031)
3.4.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Solid Phase Synthesis Carrier for Peptide Drug by Region (2026-2031)
3.5 Global Solid Phase Synthesis Carrier for Peptide Drug Market Price Analysis by Region (2020-2025)
3.6 Global Solid Phase Synthesis Carrier for Peptide Drug Production and Value, Year-over-Year Growth
3.6.1 North America Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
4 Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region
4.1 Global Solid Phase Synthesis Carrier for Peptide Drug Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2031)
4.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2025)
4.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Type (2020-2031)
5.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Type (2020-2025)
5.1.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Type (2026-2031)
5.1.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Type (2020-2031)
5.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Type (2020-2031)
5.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Type (2020-2025)
5.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Type (2026-2031)
5.2.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Type (2020-2031)
5.3 Global Solid Phase Synthesis Carrier for Peptide Drug Price by Type (2020-2031)
6 Segment by Application
6.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Application (2020-2031)
6.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Application (2020-2025)
6.1.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Application (2026-2031)
6.1.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Application (2020-2031)
6.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Application (2020-2031)
6.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Application (2020-2025)
6.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Application (2026-2031)
6.2.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Application (2020-2031)
6.3 Global Solid Phase Synthesis Carrier for Peptide Drug Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Sunresin
7.1.1 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.1.2 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.1.3 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Sunresin Main Business and Markets Served
7.1.5 Sunresin Recent Developments/Updates
7.2 Tianjin Nankai Hecheng Science & Technology
7.2.1 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.2.2 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.2.3 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Tianjin Nankai Hecheng Science & Technology Main Business and Markets Served
7.2.5 Tianjin Nankai Hecheng Science & Technology Recent Developments/Updates
7.3 Zhejiang Zhengguang
7.3.1 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.3.2 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.3.3 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Zhejiang Zhengguang Main Business and Markets Served
7.3.5 Zhejiang Zhengguang Recent Developments/Updates
7.4 Jiangsu Haipu Functional Materials
7.4.1 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.4.2 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.4.3 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jiangsu Haipu Functional Materials Main Business and Markets Served
7.4.5 Jiangsu Haipu Functional Materials Recent Developments/Updates
7.5 RawPEG
7.5.1 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.5.2 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.5.3 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.5.4 RawPEG Main Business and Markets Served
7.5.5 RawPEG Recent Developments/Updates
7.6 Merck
7.6.1 Merck Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.6.2 Merck Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.6.3 Merck Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Merck Main Business and Markets Served
7.6.5 Merck Recent Developments/Updates
7.7 CEM Corporation
7.7.1 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.7.2 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.7.3 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.7.4 CEM Corporation Main Business and Markets Served
7.7.5 CEM Corporation Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Solid Phase Synthesis Carrier for Peptide Drug Industry Chain Analysis
8.2 Solid Phase Synthesis Carrier for Peptide Drug Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Solid Phase Synthesis Carrier for Peptide Drug Production Mode & Process Analysis
8.4 Solid Phase Synthesis Carrier for Peptide Drug Sales and Marketing
8.4.1 Solid Phase Synthesis Carrier for Peptide Drug Sales Channels
8.4.2 Solid Phase Synthesis Carrier for Peptide Drug Distributors
8.5 Solid Phase Synthesis Carrier for Peptide Drug Customer Analysis
9 Solid Phase Synthesis Carrier for Peptide Drug Market Dynamics
9.1 Solid Phase Synthesis Carrier for Peptide Drug Industry Trends
9.2 Solid Phase Synthesis Carrier for Peptide Drug Market Drivers
9.3 Solid Phase Synthesis Carrier for Peptide Drug Market Challenges
9.4 Solid Phase Synthesis Carrier for Peptide Drug Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Sunresin
Tianjin Nankai Hecheng Science & Technology
Zhejiang Zhengguang
Jiangsu Haipu Functional Materials
RawPEG
Merck
CEM Corporation
听
听
*If Applicable.
